Wk 4 Signal Transduction and Metabolic Changes in Cancer Flashcards

1
Q

How does receptor-mediated signal transduction occur?

A
  1. ligand/growth factor binds receptor on cell membrane
  2. Binding causes modification to intracellular portion of receptor
  3. -> cascade of events in cytoplasm
  4. -> amplification (receptor effects 1 protein and many other effected downstream) = cytoplasmic effects
  5. nuclear effects occur too, like gene expression changes
  6. can have signal divergence = multiple pathways activated by single receptor
    7.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are 3 consequences of a ligand/growth factor binding to a cellular receptor?

A
  1. amplification ->
  2. cytoplasmic and/or nuclear effects
  3. signal divergence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are the signals turned off after ligand binding to receptor?

A
  1. negative feedback loops from downstream proteins
  2. signalling inhibitors (block b/c not ready to activate pathway)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 main proteins involved in cell signaling?

A
  1. kinases
  2. GTPases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are kinases?

A

proteins that add phosphate groups to other proteins or to themselves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 2 main types of kinases?

A
  1. tyrosine kinases - take phosphates from ATP and add them to tyrosine
  2. Serine/threonine kinases - phosphorylate serine or threonine

-phosphorylation often transitions protein to active form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are phosphatases?

A

Remove phosphates from proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are 2 examples of tyrosine kinases?

A
  1. EGFR = epidermal growth factor receptor
  2. HER2 = related protein (IMP in breast cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 examples of serine/threonine kinases

A
  1. RAF
  2. MEK
  3. AKT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens when a protein is phosphorylated?

A
  1. enable specific phospho-binding proteins to interact with it (stability, degradation, localization)
  2. if it’s an enzyme, becomes activated or inactivated
  3. Changes the protein’s conformation (expose nuclear localization sequence and translocation into nucleus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is RAS?

A

A small GTPase
-comes in 3 forms, H-Ras, K-Ras, and N-Ras

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is GDP and GTP?

A

GDP = signaling “off” = guanosine diphosphate
GTP = signaling “on” pro-cancer = guanosine triphosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are GDP and GTP?

A

guanasine diphosphate
guanasine triphosphate
=small proteins that help push GTPases from one state to another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are GAPS?

A

GTPase activating proteins - promote hydrolyzation of GTP to GDP, turning GTPases into off state
-ex. p120 Tas-GAP, NF1
-GTPase-activating proteins or GTPase-accelerating proteins (GAPs) are a family of regulatory proteins whose members can bind to activated G proteins and stimulate their GTPase activity, with the result of terminating the signaling event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are GEFs?

A

=Guanine exchange factors
-ex SOS
-proteins or protein domains that activate monomeric GTPases by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP).
-activate GTPases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are cancer associations with GTPases?

A
  1. K-ras mutations (30% lung cancers, 90% of pancreatic cancers)
  2. high levels of GEFs, like SOS
  3. loss of GAPs, like neurofibromatosis 1 (NF1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the RAS/MAPK pathway (growth factor signaling pathway) in cancer?

A
  1. EGFR or HER2 receptor is bound by ligand
  2. binding causes dimerization of the receptor
  3. -> cross-phosphorylation of the dimer
  4. phosphorylation causes activation of SOS (a GEF)
  5. -> Ras activation, promotes GTP-bound form, which
  6. binds to RAF (a serine/threonine kinase) and activates it
  7. activates other kinases (MAPK)
  8. cell proliferates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What other pathway gets activated in addition to the RAS/MAPK pathway?

A
  1. EGFR or HER2 receptor bound to ligand
  2. binding -> dimerization of receptor
  3. phosphorylation of dimer
  4. activation of PI3K
  5. activation of Akt (a kinase)
  6. PI3K/AKT pathway activated = survival and metabolic alterations
19
Q

What is the negative feedback on the RAS/MAPK and PI3K/AKT pathways?

A
  1. RAS/MAPK - NF1
  2. PI3K/AKT - PTEN (a phosphatase that opposes action of PI3K
20
Q

What are the kinases in the RAS/MAPK and PI3K/AKT pathways?

A
  1. growth factor receptor (EGFR or HER2)
  2. RAF (on RAS/MAPK)
  3. MEK (on RAS/MAPK)
  4. PI3K
  5. AKT
21
Q

What are the major metabolic differences commonly found in cancer cells?

A
22
Q

What is the Warburg Effect?

A

Dr. Warburg discovered in 1931 that cancer cells take up much more glucose than normal cells and convert about 50% of it to lactate through aerobic glycolysis instead of oxidizing it to carbon dioxide even in the presence of oxygen.
Cancer: 50% to lactate, 50% CO2
normal: 10% lactate, 90% CO2

23
Q

What happened w/ Warburg Effect?

A

Forgotten for decades, reconized again in last decade as “deregulating cellular energetics” or “metabolic reprogramming” and is a hallmark of cancer.

24
Q

What are the 2 major goals of metabolism for tumor growth?

A
  1. proliferating cells (incl cancer) need lots of ATP
  2. they also need the “biomass” - proteins, nucleic acids, lipids, structural CHO, glucose, and glutamine
25
Q

What metabolites are needed in significantly greater quantity for proliferating cells?

A

Glucose and glutamine

26
Q

What are key steps in cancer metabolism?

A
  1. increased growth factor receptors (PI3K pathway)
  2. increased glucose uptake (more GLUT transporters)
  3. increased glycolytic pathway enzymes
  4. shunting of glucose into pentose phosphate pathway to make pentose-ribose-5 phosphate (to build nucleotides w/ addition of glutamine)
  5. increased glutamine uptake (via c-myc oncoprotein)
  6. increased protein synthesis
  7. increased AA uptake (downstream from growth factor signaling)
  8. export of citrate from TCA cycle to cytosol to allow synthesis of FA
27
Q

What is a major cellular pathway to the synthesis of proteins, FA, lipids, and nucleotides in cancer cells?

A
  1. increase tyrosine kinase receptors
  2. -> increase PI3K
  3. -> increase PDK1
  4. -> increase AKT
  5. -> increase mTORC1
  6. -> increased synthesis of PRO, FA, lipids, nucleotides and increased gene expression
28
Q

What is PI3K and what is its role?

A

=phospholipid kinase
-transfers the terminal phosphate from ATP to a phospholipid, PIP2, converting it to PIP3

29
Q

What does PIP3 do?

A

activates PDK1 (protein kinase 1)

30
Q

What does PDK1 do?

A

Activates AKT (AKA protein kinase B)

31
Q

What does AKT do?

A

Activates mTor

32
Q

What does mTOR do?

A

activates and increases growth-factor dependent metabolic changes:
1. glucose transport
2. glycolytic gene expression
3. glycolytic rate
4. lipogenic gene expression
5. lipid synthesis
6. AA transport

33
Q

What is PTEN?

A

A phospholipid phosphatase that stops the PI3K (growth factor) pathway
-a tumor suppressor
-catalyzes the hydrolysis (removes the phosphate) from PIP3, converting it to PIP2 so AKT is not activated

34
Q

How does cancer affect the PI3K pathway?

A
  1. can increase growth factor receptors
  2. generate a mutant PI3K
  3. inactivate PTEN
35
Q

Where does de novo fatty acid synthesis occur?

A
  1. Liver
  2. adipose
  3. lactating breast tissue
  4. many tumors - need FA for phospholipid cell membranes
36
Q

What are the steps of fatty acid synthesis?

A
  1. get acetyl-CoA into cytosol (most made in mitochondria)
  2. produce malonyl-CoA (basically acetyl-CoA w/ another C group added by acetyl-CoA carboxylase w/ B7 (biotin) as a cofactor)
    3.
37
Q

How is cytosolic acetyl-CoA produced?

A
  1. citrate enters cytosol from mitochondria
  2. citrate lyase catalyzes ATP to donate P to citrate, CoA added -> acetyl-CoA formation, and oxaloacetate
  3. FAS reactions - catalzyes 5 reactions: forms oxidized 4C chain attached to ACP that must be reduced. NADPH reduces twice. This steps is repeated multiple times until 16C palmitate is formed and attached to ACP. ACP cleaved by thioesterase -> saturated FA C16, palmitate.
38
Q

What is malonyl-CoA?

A

acetyl-CoA w/ another C group added by acetyl-CoA carboxylase w/ B7 (biotin) as a cofactor
-key intermediate in synthesis of FA and also inhibit FA oxidation
- key inhibitor of FA oxidation (inhibits palmityl-carnitine transferase, which prevents FA from entering mitochondrial matrix)

39
Q

What does FAS do?

A

=fatty acid synthase
-combines malonyl CoA + acetyl-CoA (lose CO2) to form 4C unit attached to ACP

40
Q

What is ACP?

A

=acyl carrier protein, one of the FAS domains
-part of FA synthesis pathway

41
Q

What is palmitate?

A

A saturated FA, C16
-end product of FAS reactions for FA synthesis

42
Q

Reactions catalyzed by FAS

A
43
Q
A

C